Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma

Journal of Clinical Pathology

Volumn 56, Issue 8, 2003, Pages 579-582

  Tateishi, U ^a   Hasegawa, T ^a   Beppu, Y ^a   Kawai, A ^a   Moriyama, N ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL DEATH; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MITOSIS; MULTIVARIATE ANALYSIS; MYXOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0042591435     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.8.579     Document Type: Article

References (22)

1. Enzinger FM, Weiss SW. Soft tissue tumors, 4th ed. St Louis: Mosby Year Book, 2001.
2. Knight JC, Renwick PJ, Cin PD, et al. Translocction t(12;16)(q13;p11) in myxoid and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995;55:24-7.
3. Panagopoulos I, Mandadhl N, Ron D, et al. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res 1994;54:6500-3.
4. Kuroda M, Ishida T, Horiuchi H, et al. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol 1995;147:1221-7.
5. Hisaoka M, Tsuji S, Morimitsu Y, et al. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn Mol Pathol 1998;7:96-101.
6. Enzinger FM, Winslow DJ. Liposarcoma: a study of 103 cases. Virchows Arch Pathol Anat 1962;335:367-88.
7. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979;3:507-23.
8. Evans HL. Liposarcomas and atypical lipomatous tumors: a study of 66 cases followed for a minimum of 10 years. Surg Pathol 1988;1:41-54.
9. Hashimoto H, Enjoji M. Liposarcoma: a clinicopathologic subtyping of 52 cases. Acta Pathol Jpn 1982;32:933-48.
10. Hasegawa T, Yokoyama R, Lee YH, et al. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology 2000;58:66-74.
11. Hasegawa T, Yamamoto S, Yokoyama R, et al. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer 2002;95:843-51.
12. Hasegawa T, Yamamoto S, Nojima T, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002;33:111-15.
13. Kilpatrlck SE, Doyon J, Choong PFM, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma: a study of 95 cases. Cancer 1996;77:1450-8.
14. Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities: a clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996;20:171-80.
15. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of p53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001;7:3977-87.
16. Lack EE, Steinberg SM, White DM, et al. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying high-grade sarcomas. J Surg Oncol 1989;41:263-73.
17. Mandard AM, Petiot JF, Marnay J, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989;63:1437-51.
18. Choong PFM, Gustafson P, Willen H, et al. Prognosis following locally recurrent soft tissue sarcoma. A staging system based on primary and recurrent tumor characteristics. Int J Cancer 1995;6:33-7.
19. Dei Tos AP, Piccinin S, Doglioni C, et al. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol 1997;151:1531-9.
20. Pilotti S, Lavarino C, Mezzelani A, et al. Limited role of Tp53 and Tp53-related genes in myxoid liposarcoma. Tumori 1998;84:571-7.
21. Orson GG, Sim FH, Reiman HM, et al. Liposarcoma of the musculoskeletal system. Cancer 1987;60:362-70.
22. Reitan JB, Kaazhus O, Brenhoud IO, et al. Prognostic factors in liposarcoma. Cancer 1985;55:2482-90.